Search research articles
Contact Us
Filters
Showing results (91-100 of 158) with videos related to
Page
of 16
Sort By:
Plos One
|
May 30, 2014
Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface
Charles Oliver Morton, Mirjam Fliesser, Marcus Dittrich, et al.
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy
Luc J Huurneman, Michael Neely, Anette Veringa, et al.
The Lancet. Oncology
|
July 4, 2014
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H Groll, Elio Castagnola, Simone Cesaro, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2022
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance
Nicola Farrington, Laura McEntee, Adam Johnson, et al.
Mbio
|
January 18, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>
Nicola Farrington, Vineet Dubey, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy
|
December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
Dimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Nature Communications
|
June 13, 2026
Molecular pharmacodynamics of amoxicillin-clavulanic acid for urinary tract infections caused by Escherichia coli
Vineet Dubey, Christopher Darlow, Alessandro Gerada, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis
Christopher A Darlow, Nicola Farrington, Anne-Grete Märtson, et al.
Antimicrobial Agents and Chemotherapy
|
November 14, 2018
Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by <i>Talaromyces marneffei</i>
Thuy Le, Vo Trieu Ly, Nguyen Thi Mai Thu, et al.
Antimicrobial Agents and Chemotherapy
|
May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections
Laura McEntee, Adam Johnson, Nicola Farrington, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 158) with videos related to
Sort By:
Page
of 16
Plos One
|
May 30, 2014
Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface
Charles Oliver Morton, Mirjam Fliesser, Marcus Dittrich, et al.
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy
Luc J Huurneman, Michael Neely, Anette Veringa, et al.
The Lancet. Oncology
|
July 4, 2014
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H Groll, Elio Castagnola, Simone Cesaro, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2022
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance
Nicola Farrington, Laura McEntee, Adam Johnson, et al.
Mbio
|
January 18, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>
Nicola Farrington, Vineet Dubey, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy
|
December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
Dimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Nature Communications
|
June 13, 2026
Molecular pharmacodynamics of amoxicillin-clavulanic acid for urinary tract infections caused by Escherichia coli
Vineet Dubey, Christopher Darlow, Alessandro Gerada, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis
Christopher A Darlow, Nicola Farrington, Anne-Grete Märtson, et al.
Antimicrobial Agents and Chemotherapy
|
November 14, 2018
Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by <i>Talaromyces marneffei</i>
Thuy Le, Vo Trieu Ly, Nguyen Thi Mai Thu, et al.
Antimicrobial Agents and Chemotherapy
|
May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections
Laura McEntee, Adam Johnson, Nicola Farrington, et al.
Page
of 16